Zeaxanthin: Benefits, Dosage, Contraindications

Updated on

Zeaxanthin, and its isomer lutein, are both non-vitamin carotenoids, meaning they cannot convert into vitamin A and, along with their common metabolite (meso-zeaxanthin), are termed macular pigments. When ingested, zeaxanthin is carried from the intestine to the liver via chylomicrons. It is then transported by low-density lipoproteins (LDL) and high-density lipoproteins (HDL) to different parts of the body. Zeaxanthin is present in the eye, blood serum, skin, cervix, brain, breast, and adipose tissue. In the eye, zeaxanthin is primarily concentrated at the center of the retina and cones, giving the yellow spot of the retina its characteristic color. Zeaxanthin filters ultraviolet rays that could damage the light-detecting cells. It is also found in smaller quantities in the lens (the lens that focuses light on the retina) where it fulfills a similar function. Zeaxanthin is not made by the body and must be obtained through the diet. Foods vary in their lutein and zeaxanthin content, with lutein generally more abundant. Zeaxanthin is found in corn, spinach, zucchini, broccoli, peas, corn, kiwis, oranges, mangoes, and egg yolk. Goji berries are a very rich source of zeaxanthin. Lutein, zeaxanthin, and meso-zeaxanthin are primarily extracted from marigold flowers or tagetes (Tagetes erecta) for use in supplements.

Other name(s) 

Lutein

Family or group: 

Phytosubstances


Indications

Rating methodology

EFSA approval.

Several clinical trials (> 2) randomized controlled with double blind, including a significant number of patients (>100) with consistently positive outcomes for the indication.
Several clinical trials (> 2) randomized controlled with double blind, and including a significant number of patients (>100) with positive outcomes for the indication.
One or more randomized studies or multiple cohorts or epidemiological studies with positive outcomes for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or contradictory.
Lack of clinical studies to date that can demonstrate the indication.


AMD
✪✪✪✪

Epidemiological research has shown that individuals who consume higher amounts of lutein and zeaxanthin in their diet have a reduced risk of developing AMD. A meta-analysis shows that taking a carotenoid (lutein, zeaxanthin, or meso-zeaxanthin) improves macular optical density compared to a placebo in patients with or without AMD. More recently, a double-blind, placebo-controlled study revealed that macular pigment density and visual acuity are significantly corrected in patients with non-exudative AMD, after taking a combination of lutein (10-20 mg), zeaxanthin (1-2 mg), omega-3 fatty acids (100-200 mg of docosahexaenoic acid and 30-60 mg of eicosapentaenoic acid), and antioxidants, over a period of 12 months.

Posologie

posologieOrally

posologie1 - 2 mg

duration12 - months


Eye Health
✪✪✪✪

Foods with high concentrations of lutein and zeaxanthin are more beneficial for eye health than other carotenoids and antioxidants like vitamin A, lycopene, alpha or beta carotene, vitamin C, and vitamin E. In fact, the yellow color of lutein and zeaxanthin is due to their ability to absorb blue light. They act as "sunglasses" that function as a filter for blue light, thus reducing chromatic aberration and helping prevent damage to photoreceptors. Moreover, epidemiological research has shown that people who consume higher amounts of lutein and zeaxanthin in their diet have a reduced risk of developing AMD (age-related macular degeneration).

Posologie

posologieOrally

posologie2 - 5 mg


Non-Hodgkin Lymphoma
✪✪✪✪✪

An analysis of population-based observational research shows that increased consumption of lutein and zeaxanthin in the diet is associated with an 18% reduced risk of developing non-Hodgkin lymphoma compared to low dietary intake.

Posologie

posologieOrally

posologie20 mg


Skin Health
✪✪✪✪✪

Lutein and zeaxanthin appear to protect against UV radiation damage due to their antioxidant effects. Animal studies suggest that lutein reduces the risk of sunburn, UV-induced immunosuppression, decreases reactive oxygen species, and directly protects against photoaging and photocarcinogenesis. There is evidence suggesting that supplementation with lutein and zeaxanthin could improve overall skin health and simultaneously help minimize signs of premature aging.

Posologie

posologieOrally

posologie6 - 10 mg


Breast Cancer
✪✪✪✪✪

Epidemiological research has shown that a high serum level of lutein and zeaxanthin is associated with a reduced risk of developing breast cancer.

Posologie

posologieOrally

posologie6 - 10 mg


Lung Cancer
✪✪✪✪✪

Epidemiological research has shown that low serum levels of carotenoids, including lutein and zeaxanthin, are associated with an increased risk of lung cancer. However, other epidemiological studies have shown that a higher serum level or greater dietary intake of lutein is not associated with a reduced risk of developing lung cancer. These results are contrasted with those of a case-control study conducted on 108 cases of lung cancer, which found that higher levels of serum carotenoids, including lutein and zeaxanthin, were significantly associated with an increased risk of lung cancer in alcoholic subjects, while potentially having a protective effect in non-drinkers.

Posologie

posologieOrally

posologie6 - 10 mg


Uterine Cancer
✪✪✪✪✪

A study suggests that lutein and zeaxanthin are likely to have a protective effect against cervical cancer and possibly against the persistence of the human papillomavirus (HPV) (a DNA virus that can be a precursor of anogenital cancers, including cervical cancer). However, other epidemiological studies have shown that low dietary lutein intake does not increase the risk of developing cervical cancer.

Posologie

posologieOrally

posologie6 - 10 mg


Colorectal Cancer
✪✪✪✪✪

Some epidemiological research has shown a reduction in the risk of developing colon cancer among individuals consuming large amounts of dietary lutein and zeaxanthin.

Posologie

posologieOrally

posologie6 - 10 mg


Properties


Vision

full-leaffull-leaffull-leafempty-leaf

Foods containing high concentrations of lutein and zeaxanthin are more beneficial for eye health than other carotenoids and antioxidants such as vitamin A, lycopene, alpha or beta carotene, vitamin C, and vitamin E. The yellow color of lutein and zeaxanthin is due to their ability to absorb blue light. Hence, they act as "sunglasses" that filter blue light, thereby reducing chromatic aberration and preventing photoreceptor damage. On the other hand, it is generally accepted that macular pigment density decreases with age, although results are conflicting. Moreover, epidemiological evidence has linked high dietary intake of lutein and zeaxanthin with increased optical density of macular pigments and reduced risk of developing age-related macular degeneration (AMD) and cataracts.

Usages associés

Cataracts, AMD, Eye Health

Essential

full-leaffull-leaffull-leafempty-leaf

Zeaxanthin and lutein can be considered conditionally essential nutrients because low serum levels or low dietary intake are associated with an increased risk of age-related macular degeneration (AMD). Epidemiological studies have also highlighted an association of low serum carotenoid levels, including lutein and zeaxanthin levels, with all-cause mortality, risk of inflammatory arthritis, prostate cancer, colon cancer, cervical cancer, persistent human papillomavirus infection, type 2 diabetes and impaired glucose metabolism, chronic cholestatic liver diseases, Alzheimer's disease, and vascular dementia.

Usages associés

AMD

Dermatological Effect

full-leaffull-leafempty-leafempty-leaf

Lutein and zeaxanthin appear to protect against damage caused by UV radiation through antioxidant effects. The protective effect of lutein and zeaxanthin against skin cancer is uncertain. Additionally, there is evidence suggesting that supplementation with lutein and zeaxanthin could improve overall skin health and simultaneously help minimize signs of premature aging. A double-blind, placebo-controlled study examined surface lipids, hydration status, photoprotective activity, elasticity, and lipid peroxidation of the skin and revealed that oral and/or topical administration of lutein or zeaxanthin provide antioxidant protection. This protection is greater with the combined administration of lutein and zeaxanthin.

Usages associés

Skin Health

Antioxidant

full-leaffull-leafempty-leafempty-leaf

Zeaxanthin appears to have a direct antioxidant potential against peroxyl radicals, being capable of scavenging them, whether they are water-soluble or lipid-soluble.

Usages associés

Eye Health

Anticancer

full-leafempty-leafempty-leafempty-leaf

The level of lutein in breast adipose tissue seems to be influenced by diet, which may explain the lower incidence of certain cancers with increased fruit and vegetable consumption. Epidemiological evidence shows that high dietary intake of lutein and zeaxanthin has been associated with a reduced risk of certain cancers, particularly endometrial and ovarian cancer, but not all cancers.

Usages associés

Breast Cancer, Lung Cancer, Cervical Cancer, Colorectal Cancer, Non-Hodgkin Lymphoma

Immuno-modulator

full-leafempty-leafempty-leafempty-leaf

In a case-control study, serum lutein and zeaxanthin, along with other carotenoids, were lower in children with acute phase infection compared to healthy controls.


Safety dosage

Adult from 18 years: 6 mg - 20 mg

The recommended doses of carotenoids are in the range of 6 to 10 mg per day and should never exceed 20 mg per day.

Adolescent from 16 years:

The recommended doses of carotenoids are in the range of 6 to 10 mg per day and should never exceed 20 mg per day.


Interactions

Médicaments

Orlistat: moderate interaction

Theoretically, long-term use of orlistat leads to reduced plasma levels of zeaxanthin due to decreased gastric absorption.

Plantes ou autres actifs

Zeaxanthin: moderate interaction

Long-term use of olestra (a fat substitute) may decrease serum lutein and zeaxanthin levels.


Precautions

Pregnant woman: avoid

Pregnant women should refrain from taking carotenoids and stick to those provided by food.

Breastfeeding woman: avoid

Breastfeeding women should refrain from taking carotenoids and stick to those provided by food.

Child up to 15 years: avoid

It is not recommended for pregnant or breastfeeding women and for children under 15.


Contraindications

Cancer: prohibited

Prohibited (beyond the doses present in the diet) for anyone with cancer to avoid reducing the effectiveness of treatments (according to the general recommendation: no antioxidant intake in case of cancer pathology).